Oliver Naucke of Uhlmann Pac-Systeme GmbH explains the concept of – “7×4 Box – My week´s medicine”. To ensure consistent compliance, especially in the case of chronically ill and older people, 7×4 Pharma GmbH commenced a pilot project with the compulsory health insurance AOK Berlin in 2009 to supply patients with individually-packed blisters with their weekly medication.
There are approximately 881,000 malaria-related deaths every year. Drs Nadia elMasry and Chemtai Kipkeu show how Novartis Pharma AG is doing in the fight against malaria.
Anne Dallison of Design Cognition Ltd argues that this change will dramatically increase the safety and sense of security of the many Braille users in Europe.
This article by Richard Burhouse of Payne Security discusses the issue of counterfeit drugs, outlines current legislation and discusses the latest secure packaging technologies and their unique benefits.
Chris Johnson of CYPAK writes on how products conforming to IEEE 11073-10472 and Continua Health Alliance will have a major impact on the way pharmaceuticals are packaged and delivered in future.
This article by Hyaluron Contract Manufacturing focuses on elements to consider when choosing to outsource drug production.
Anton Gerdenitsch of Fresenius Kabi evaluates the proposition that, when emulsions are carefully designed with respect to the target and route of administration, they may provide one solution to some of the delivery problems posed by new classes of active molecules, such as peptides, proteins, genes, and oligonucleotides. They may also extend the therapeutic potential of established drugs.
Nathan Kohner of Almac Group explains that a process for the efficient visibility of the success of temperature control increases detectability, and therefore reduces the risk factor.
Brian Sanderson of Chiltern (Early Phase) argues that although new studies have their place, the more traditional Phase I studies have evolved over the years, with new thinking being applied along with a wealth of expertise available to add value.
Amy Furlong, Executive Vice President, Cardiac Safety Operations at ERT shows how centralising the process of collection and standardisation of quality ECG data, and employing digital ECG systems and a core laboratory, not only reduces inconsistencies that may occur from site to site, but in addition helps to alleviate laboratory and site workloads.
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
